ClinicalTrials.Veeva

Menu

Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia (SMILE)

T

Toulouse University Hospital

Status

Not yet enrolling

Conditions

Dental Diseases

Treatments

Other: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT06506734
RC31/23/0443

Details and patient eligibility

About

The main objective of this study is to assess the prevalence of dental discoloration (dental dyschromia) in children who experienced high levels of bilirubin in their blood (hyperbilirubinemia) during their early years. The study will also examine risk factors associated with this condition, such as the duration and severity of hyperbilirubinemia, underlying diseases, and treatments received.

The researchers hypothesize that the quality of life of individuals with dental dyschromia is lower than that of individuals without dyschromia. The results of this study will be used to discuss coverage for dental care with health insurance for children affected by this condition.

Enrollment

120 estimated patients

Sex

All

Ages

12 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A patient with biliary atresia, progressive familial intrahepatic cholestasis, or Alagille syndrome
  • Patient or legal representative not opposed to participating in this research.

Exclusion criteria

  • Inability to understand and respond to quality of life questionnaires

Trial design

120 participants in 1 patient group

Dental Dyschromia in Hyperbilirubinemia Patients
Description:
30 minutes
Treatment:
Other: Questionnaires

Trial contacts and locations

9

Loading...

Central trial contact

Romain LOPEZ, PharmD; Nolwenn LABORDE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems